Welcome to Shionogi U.S. Medical

Your source for balanced, evidence-based medical information and important scientific resources on Shionogi medicines and investigational compounds.

Gram-negative Infections

COVID-19 & RSV

Rare Diseases

Search the Shionogi U.S. Medical Site

Find healthcare professional resources, publications, and congress materials

  • Select medicine or disease state
  • Medicines
  • Cefiderocol (FETROJA®)
  • Edaravone (RADICAVA ORS®)
  • Ensitrelvir (XOCOVA®)
  • Investigational Compounds
  • S-337395
  • Secutrelvir
  • Xeruborbactam
  • Zatolmilast
  • Disease States
  • Amyotrophic Lateral Sclerosis (ALS)
  • COVID-19
  • Fragile X syndrome
  • Gram-negative Infections
  • Respiratory Syncytial Virus (RSV)

Featured Resources

Explore a curated selection of medical and scientific resources to support the clinical understanding of patient care.

  • Difficult-to-Treat <em>P. aeruginosa</em>: In Vitro Insights on BL-BLI Cross-Resistance from the SENTRY Program
    Downloadable PDF
    Infographic

    Difficult-to-Treat P. aeruginosa: In Vitro Insights on BL-BLI Cross-Resistance from the SENTRY Program

    View/Download Resource
  • After Exposure, Then What? Closing the COVID-19 Prevention Gap
    External Link

    After Exposure, Then What? Closing the COVID-19 Prevention Gap

    View Resource
  • Spectrum of Activity of Contemporary Antibiotics Against Resistant Gram-Negative Pathogens
    Downloadable PDF
    Infographic

    Spectrum of Activity of Contemporary Antibiotics Against Resistant Gram-Negative Pathogens

    View/Download Resource

Access Congress Materials & Publications

See recent Shionogi-sponsored congress presentations and publications

Congresses
Publications

Report an Adverse Event (AE) or Product Quality Complaint (PQC)

We continue to monitor all of our products

Report an AE or PQC